Michael Honaker, MD
Colon & Rectal Surgery · Greenville, NCNPI 1700010394
Payments from drug & device makers
What this record shows
Applied Medical Resources Corporation accounts for 67.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $921 and has fallen 90.9% since, to $84 in 2025. That places this record below the midpoint for colon & rectal surgery clinicians in NC, where the typical reported total is $3,517.
Across 19 payments — averaging $66.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Medical Resources Corporation$857
- Axonics, Inc.$133
- Biom'up France SAS$52
- Takeda Pharmaceuticals U.S.A., Inc.$45
- AbbVie$42
- Olympus America Inc.$39
- plus $97 from 5 others
What the payments were for
- Travel & lodging$75359%
- Food & beverage$51241%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Medical Resources Corporation | 4 | $857 |
| Axonics, Inc. | 3 | $133 |
| Biom'up France SAS | 1 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| AbbVie | 2 | $42 |
| Olympus America Inc. | 1 | $39 |
| Acell, Inc. | 1 | $25 |
| Medtronic | 1 | $20 |
| AstraZeneca | 1 | $20 |
| THD America, Inc. | 2 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GELPOINT PATH$730
How this compares
$1,265 in reported general payments places this provider in the 40th percentile of 27 colon & rectal surgery providers in North Carolina.
See all colon & rectal surgery providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 31 | $451 |
| Neomycin Sulfate | 28 | $168 |
| Oxycodone Hcl | 11 | $70 |
| Metronidazole | 29 | $57 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Greenville
- Warqaa AkramGreenville$4K
- Patrick BrillantGreenville$710
- Benny ChongConcord$32K
- Coen KlosHendersonville$14K
- Julie ThackerDurham$14K
- William LymanCharlotte$11K
- Joseph PayneWilmington$9K
- Stanley FullerWinston Salem$8K
- Bradley DavisCharlotte$7K
- Guillaume ChevrollierCharlotte$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.